-
Investors Demonstrate Disappoint Over Return Of Valeant CEO From Sick Leave, Downgrade And Guidance Withdrawal
Monday, February 29, 2016 - 12:19pm | 129Read More...Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares are trading lower by $7.7 at $73.58 in Monday's session. The Street appears to not be pleased with the return of its CEO from sick leave, the withdrawal of prior guidance and the TD Securities downgrade to Hold from Buy. After a lower open, it...

